New Batches
Brand new clinical-grade molecules or additional batches of existing ones, added recently to the in-stock potfolio
Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
Classes of molecules
Isotypes
Expiry Date
CoA
Filters
Sort results
Reset
Apply
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price | |
---|---|---|---|---|---|---|---|---|---|---|
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
– |
4 mg |
-80°C |
11/2023 |
675,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Hulio® |
50 mg/mL |
– |
2 mg |
-80°C |
02/2023 |
310,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Hukyndra® |
100 mg/mL |
– |
2 mg |
-80°C |
10/2023 |
521,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Yuflyma® |
100 mg/mL |
– |
4 mg |
-80°C |
02/2024 |
520,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Idacio® |
50 mg/mL |
– |
2 mg |
-80°C |
10/2023 |
454,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Imraldi® |
50 mg/mL |
– |
2 mg |
-80 °C |
10/2023 |
298,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Hyrimoz® |
50 mg/mL |
– |
2 mg |
-80°C |
06/2024 |
310,00 € |
||
IL-2RB |
Recombinant protein |
Proleukin® |
1,1 mg/mL |
– |
0,044 mg |
-80°C |
07/2024 |
417,00 € |
||
PD-L1 |
Monoclonal Antibody-Fc engineered |
Tecentriq® |
60 mg/mL |
yes |
12 mg |
-80°C |
05/2023 |
508,00 € |
||
CD80 , CD86 |
Fusion protein |
Nulojix® |
25 mg/mL |
– |
5 mg |
-80°C |
01/2025 |
235,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
yes |
2 mg |
-80°C |
07/2024 |
238,00 € |
||
CD30 |
Antibody-drug conjugate (ADC) |
Adcetris® |
5 mg/mL |
– |
2 mg |
-80°C |
02/2025 |
888,00 € |
||
CD38 |
Monoclonal Antibody |
Darzalex® |
20 mg/mL |
– |
4 mg |
-80°C |
11/2023 |
500,00 € |
||
CD38 |
Monoclonal Antibody |
Darzalex® |
20 mg/mL |
– |
2 mg |
-80°C |
07/2023 |
362,00 € |
||
DNA in cystic fibrosis mucus |
Enzyme |
Pulmozyme® |
1 mg/mL |
– |
0.3 mg |
-80°C |
12/2023 |
180,00 € |
||
GLP-1 |
Hormone , Therapeutic peptides |
Trulicity® |
3 mg/mL |
– |
0.9 mg |
-80°C |
04/2024 |
460,00 € |
||
GLP-1 |
Hormone , Therapeutic peptides |
Trulicity® |
3 mg/mL |
– |
0.9 mg |
-80°C |
12/2023 |
460,00 € |
||
IL-13 , IL-4 |
Monoclonal Antibody |
Dupixent® |
150 mg/mL |
yes |
12 mg |
-80°C |
11/2024 |
467,00 € |
||
Clotting Factor IXa and X |
Bispecific Antibody |
Hemlibra® |
30 mg/mL |
– |
2 mg |
-80°C |
09/2023 |
803,00 € |
||
Nectin-4 |
Antibody-drug conjugate (ADC) |
Padcev® |
10 mg/mL |
– |
1 mg |
-80 °C |
12/2023 |
480,00 € |
||
TNF alpha |
Biosimilar , Fusion protein |
Erelzi® |
50 mg/mL |
– |
4 mg |
-80°C |
04/2023 |
249,00 € |
||
TNF alpha |
Biosimilar , Fusion protein |
Nepexto® |
50 mg/mL |
– |
4 mg |
-80 °C |
08/2023 |
249,00 € |
||
CD33 |
Antibody-drug conjugate (ADC) |
Mylotarg® |
1 mg/mL |
– |
0,1 mg |
-80°C |
08/2024 |
862,00 € |
||
IL-23 |
Monoclonal Antibody |
Tremfya® |
100 mg/mL |
yes |
4 mg |
-80°C |
12/2023 |
747,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Flixabi® |
10 mg/mL |
– |
2 mg |
-80°C |
01/2025 |
239,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Inflectra® |
10 mg/mL |
– |
2 mg |
- 80°C |
03/2027 |
239,00 € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
yes |
2 mg |
-80°C |
11/2024 |
285,00 € |
||
CTLA-4 |
Monoclonal Antibody |
Yervoy® |
5 mg/mL |
yes |
2 mg |
-80°C |
09/2024 |
952,00 € |
||
IL-17A , IL-17A/F |
Monoclonal Antibody |
Taltz® |
80 mg/mL |
– |
4 mg |
-80 °C |
08/2023 |
490,00 € |
||
TGF-beta |
Fusion protein |
Reblozyl® |
50 mg/mL |
– |
2 mg |
-80°C |
07/2023 |
780,00 € |
Therapeutic Molecules Biologics ADCs Monoclonal antibodies Bispecific antibodies Reference products
aliquoted from medicines
-
Which molecule(s)
are you looking for?